 | • レポートコード：QYR9ST03841 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、がん治療の世界市場について調査・分析し、がん治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（免疫学的およびワクチン的アプローチ、抗増殖的アプローチ、光線力学療法、遺伝子療法アプローチ、細胞周期およびアポトーシスアプローチ）、用途別（病院用、診療所用、家庭用、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のがん治療市場動向 ・主要企業別マーケットシェア ・がん治療の種類別市場規模2014-2019 （免疫学的およびワクチン的アプローチ、抗増殖的アプローチ、光線力学療法、遺伝子療法アプローチ、細胞周期およびアポトーシスアプローチ） ・がん治療の用途別市場規模2014-2019 （病院用、診療所用、家庭用、その他） ・がん治療の北米市場：主要企業・種類別/用途別市場規模 ・がん治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・がん治療の中国市場：主要企業・種類別/用途別市場規模 ・がん治療の日本国内市場：主要企業・種類別/用途別市場規模 ・がん治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・がん治療のインド市場：主要企業・種類別/用途別市場規模 ・がん治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Amgen、AstraZeneca、Bristol-Myers Squibb、Bayer AG、F. Hoffmann-La Roche Ltd、GlaxoSmithKline PLC、Johnson & Johnson、Merck & Co. Inc.、Novartis AG、Pfizer Inc.） ・がん治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Cancer therapy describes the treatment of cancer in a patient, often with surgery, chemotherapy and/or radiotherapy. Targeted therapies are also available for some cancer types. A cancer patient might receive many different types of therapy, including those aimed at relieving the symptoms of cancer, such as pain.North America dominates the global cancer therapy market, owing to high prevalence of cancer in the region because of a sedentary lifestyle, along with launch and growing adoption of novel cancer therapy in the region.
Asia-Pacific is expected to grow tremendously during the forecast period, owing to factors, such as high prevalence of cancer, growing awareness regarding cure and treatment of cancer, and increasing collaboration between public and private sectors to provide novel cancer therapy in the region.
In 2018, the global Cancer Therapies market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Cancer Therapies status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cancer Therapies development in United States, Europe and China.
The key players covered in this study
Amgen
AstraZeneca
Bristol-Myers Squibb
Bayer AG
F. Hoffmann-La Roche Ltd
GlaxoSmithKline PLC
Johnson & Johnson
Merck & Co. Inc.
Novartis AG
Pfizer Inc.
Market segment by Type, the product can be split into
Immunological and Vaccine Approaches
Antiproliferative Approaches
Photodynamic Therapy
Gene Therapy Approaches
Cell Cycle and Apoptosis Approaches
Market segment by Application, split into
Hospital Use
Clinic Use
Household
Other
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Cancer Therapies status, future forecast, growth opportunity, key market and key players.
To present the Cancer Therapies development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Cancer Therapies are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Cancer Therapies Market Size Growth Rate by Type (2014-2025)
1.4.2 Immunological and Vaccine Approaches
1.4.3 Antiproliferative Approaches
1.4.4 Photodynamic Therapy
1.4.5 Gene Therapy Approaches
1.4.6 Cell Cycle and Apoptosis Approaches
1.5 Market by Application
1.5.1 Global Cancer Therapies Market Share by Application (2014-2025)
1.5.2 Hospital Use
1.5.3 Clinic Use
1.5.4 Household
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Cancer Therapies Market Size
2.2 Cancer Therapies Growth Trends by Regions
2.2.1 Cancer Therapies Market Size by Regions (2014-2025)
2.2.2 Cancer Therapies Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Cancer Therapies Market Size by Manufacturers
3.1.1 Global Cancer Therapies Revenue by Manufacturers (2014-2019)
3.1.2 Global Cancer Therapies Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Cancer Therapies Market Concentration Ratio (CR5 and HHI)
3.2 Cancer Therapies Key Players Head office and Area Served
3.3 Key Players Cancer Therapies Product/Solution/Service
3.4 Date of Enter into Cancer Therapies Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Cancer Therapies Market Size by Type (2014-2019)
4.2 Global Cancer Therapies Market Size by Application (2014-2019)
5 United States
5.1 United States Cancer Therapies Market Size (2014-2019)
5.2 Cancer Therapies Key Players in United States
5.3 United States Cancer Therapies Market Size by Type
5.4 United States Cancer Therapies Market Size by Application
6 Europe
6.1 Europe Cancer Therapies Market Size (2014-2019)
6.2 Cancer Therapies Key Players in Europe
6.3 Europe Cancer Therapies Market Size by Type
6.4 Europe Cancer Therapies Market Size by Application
7 China
7.1 China Cancer Therapies Market Size (2014-2019)
7.2 Cancer Therapies Key Players in China
7.3 China Cancer Therapies Market Size by Type
7.4 China Cancer Therapies Market Size by Application
8 Japan
8.1 Japan Cancer Therapies Market Size (2014-2019)
8.2 Cancer Therapies Key Players in Japan
8.3 Japan Cancer Therapies Market Size by Type
8.4 Japan Cancer Therapies Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Cancer Therapies Market Size (2014-2019)
9.2 Cancer Therapies Key Players in Southeast Asia
9.3 Southeast Asia Cancer Therapies Market Size by Type
9.4 Southeast Asia Cancer Therapies Market Size by Application
10 India
10.1 India Cancer Therapies Market Size (2014-2019)
10.2 Cancer Therapies Key Players in India
10.3 India Cancer Therapies Market Size by Type
10.4 India Cancer Therapies Market Size by Application
11 Central & South America
11.1 Central & South America Cancer Therapies Market Size (2014-2019)
11.2 Cancer Therapies Key Players in Central & South America
11.3 Central & South America Cancer Therapies Market Size by Type
11.4 Central & South America Cancer Therapies Market Size by Application
12 International Players Profiles
12.1 Amgen
12.1.1 Amgen Company Details
12.1.2 Company Description and Business Overview
12.1.3 Cancer Therapies Introduction
12.1.4 Amgen Revenue in Cancer Therapies Business (2014-2019)
12.1.5 Amgen Recent Development
12.2 AstraZeneca
12.2.1 AstraZeneca Company Details
12.2.2 Company Description and Business Overview
12.2.3 Cancer Therapies Introduction
12.2.4 AstraZeneca Revenue in Cancer Therapies Business (2014-2019)
12.2.5 AstraZeneca Recent Development
12.3 Bristol-Myers Squibb
12.3.1 Bristol-Myers Squibb Company Details
12.3.2 Company Description and Business Overview
12.3.3 Cancer Therapies Introduction
12.3.4 Bristol-Myers Squibb Revenue in Cancer Therapies Business (2014-2019)
12.3.5 Bristol-Myers Squibb Recent Development
12.4 Bayer AG
12.4.1 Bayer AG Company Details
12.4.2 Company Description and Business Overview
12.4.3 Cancer Therapies Introduction
12.4.4 Bayer AG Revenue in Cancer Therapies Business (2014-2019)
12.4.5 Bayer AG Recent Development
12.5 F. Hoffmann-La Roche Ltd
12.5.1 F. Hoffmann-La Roche Ltd Company Details
12.5.2 Company Description and Business Overview
12.5.3 Cancer Therapies Introduction
12.5.4 F. Hoffmann-La Roche Ltd Revenue in Cancer Therapies Business (2014-2019)
12.5.5 F. Hoffmann-La Roche Ltd Recent Development
12.6 GlaxoSmithKline PLC
12.6.1 GlaxoSmithKline PLC Company Details
12.6.2 Company Description and Business Overview
12.6.3 Cancer Therapies Introduction
12.6.4 GlaxoSmithKline PLC Revenue in Cancer Therapies Business (2014-2019)
12.6.5 GlaxoSmithKline PLC Recent Development
12.7 Johnson & Johnson
12.7.1 Johnson & Johnson Company Details
12.7.2 Company Description and Business Overview
12.7.3 Cancer Therapies Introduction
12.7.4 Johnson & Johnson Revenue in Cancer Therapies Business (2014-2019)
12.7.5 Johnson & Johnson Recent Development
12.8 Merck & Co. Inc.
12.8.1 Merck & Co. Inc. Company Details
12.8.2 Company Description and Business Overview
12.8.3 Cancer Therapies Introduction
12.8.4 Merck & Co. Inc. Revenue in Cancer Therapies Business (2014-2019)
12.8.5 Merck & Co. Inc. Recent Development
12.9 Novartis AG
12.9.1 Novartis AG Company Details
12.9.2 Company Description and Business Overview
12.9.3 Cancer Therapies Introduction
12.9.4 Novartis AG Revenue in Cancer Therapies Business (2014-2019)
12.9.5 Novartis AG Recent Development
12.10 Pfizer Inc.
12.10.1 Pfizer Inc. Company Details
12.10.2 Company Description and Business Overview
12.10.3 Cancer Therapies Introduction
12.10.4 Pfizer Inc. Revenue in Cancer Therapies Business (2014-2019)
12.10.5 Pfizer Inc. Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Cancer Therapies Key Market Segments
Table Key Players Cancer Therapies Covered
Table Global Cancer Therapies Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Cancer Therapies Market Size Market Share by Type 2014-2025
Figure Immunological and Vaccine Approaches Figures
Table Key Players of Immunological and Vaccine Approaches
Figure Antiproliferative Approaches Figures
Table Key Players of Antiproliferative Approaches
Figure Photodynamic Therapy Figures
Table Key Players of Photodynamic Therapy
Figure Gene Therapy Approaches Figures
Table Key Players of Gene Therapy Approaches
Figure Cell Cycle and Apoptosis Approaches Figures
Table Key Players of Cell Cycle and Apoptosis Approaches
Table Global Cancer Therapies Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Use Case Studies
Figure Clinic Use Case Studies
Figure Household Case Studies
Figure Other Case Studies
Figure Cancer Therapies Report Years Considered
Table Global Cancer Therapies Market Size 2014-2025 (Million US$)
Figure Global Cancer Therapies Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Cancer Therapies Market Size by Regions 2014-2025 (Million US$)
Table Global Cancer Therapies Market Size by Regions 2014-2019 (Million US$)
Table Global Cancer Therapies Market Share by Regions 2014-2019
Figure Global Cancer Therapies Market Share by Regions 2014-2019
Figure Global Cancer Therapies Market Share by Regions 2019
Table Market Top Trends
Table Global Cancer Therapies Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Cancer Therapies Market Share by Manufacturers (2014-2019)
Figure Global Cancer Therapies Market Share by Manufacturers in 2018
Table Global Cancer Therapies Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Cancer Therapies Product/Solution/Service
Table Date of Enter into Cancer Therapies Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Cancer Therapies Market Size by Type (2014-2019) (Million US$)
Table Global Cancer Therapies Market Size Share by Type (2014-2019)
Figure Global Cancer Therapies Market Size Market Share by Type (2014-2019)
Table Global Cancer Therapies Market Size by Application (2014-2019) (Million US$)
Table Global Cancer Therapies Market Size Share by Application (2014-2019)
Figure Global Cancer Therapies Market Size Market Share by Application (2014-2019)
Figure Global Cancer Therapies Revenue Market Share by Application in 2018
Figure United States Cancer Therapies Market Size 2014-2019 (Million US$)
Table United States Key Players Cancer Therapies Revenue (2018-2019) (Million US$)
Table United States Key Players Cancer Therapies Market Share (2018-2019)
Table United States Cancer Therapies Market Size by Type (2014-2019) (Million US$)
Table United States Cancer Therapies Market Share by Type (2014-2019)
Table United States Cancer Therapies Market Size by Application (2014-2019) (Million US$)
Table United States Cancer Therapies Market Share by Application (2014-2019)
Figure Europe Cancer Therapies Market Size 2014-2019 (Million US$)
Table Europe Key Players Cancer Therapies Revenue (2018-2019) (Million US$)
Table Europe Key Players Cancer Therapies Market Share (2018-2019)
Table Europe Cancer Therapies Market Size by Type (2014-2019) (Million US$)
Table Europe Cancer Therapies Market Share by Type (2014-2019)
Table Europe Cancer Therapies Market Size by Application (2014-2019) (Million US$)
Table Europe Cancer Therapies Market Share by Application (2014-2019)
Figure China Cancer Therapies Market Size 2014-2019 (Million US$)
Table China Key Players Cancer Therapies Revenue (2018-2019) (Million US$)
Table China Key Players Cancer Therapies Market Share (2018-2019)
Table China Cancer Therapies Market Size by Type (2014-20189) (Million US$)
Table China Cancer Therapies Market Share by Type (2014-2019)
Table China Cancer Therapies Market Size by Application (2014-2019) (Million US$)
Table China Cancer Therapies Market Share by Application (2014-2019)
Figure Japan Cancer Therapies Market Size 2014-2019 (Million US$)
Table Japan Key Players Cancer Therapies Revenue (2018-2019) (Million US$)
Table Japan Key Players Cancer Therapies Market Share (2018-2019)
Table Japan Cancer Therapies Market Size by Type (2014-2019) (Million US$)
Table Japan Cancer Therapies Market Share by Type (2014-2019)
Table Japan Cancer Therapies Market Size by Application (2014-2019) (Million US$)
Table Japan Cancer Therapies Market Share by Application (2014-2019)
Figure Southeast Asia Cancer Therapies Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Cancer Therapies Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Cancer Therapies Market Share (2018-2019)
Table Southeast Asia Cancer Therapies Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Cancer Therapies Market Share by Type (2014-2019)
Table Southeast Asia Cancer Therapies Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Cancer Therapies Market Share by Application (2014-2019)
Figure India Cancer Therapies Market Size 2014-2019 (Million US$)
Table India Key Players Cancer Therapies Revenue (2018-2019) (Million US$)
Table India Key Players Cancer Therapies Market Share (2018-2019)
Table India Cancer Therapies Market Size by Type (2014-2019) (Million US$)
Table India Cancer Therapies Market Share by Type (2014-2019)
Table India Cancer Therapies Market Size by Application (2014-2019) (Million US$)
Table India Cancer Therapies Market Share by Application (2014-2019)
Figure Central & South America Cancer Therapies Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Cancer Therapies Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Cancer Therapies Market Share (2018-2019)
Table Central & South America Cancer Therapies Market Size by Type (2014-2019) (Million US$)
Table Central & South America Cancer Therapies Market Share by Type (2014-2019)
Table Central & South America Cancer Therapies Market Size by Application (2014-2019) (Million US$)
Table Central & South America Cancer Therapies Market Share by Application (2014-2019)
Table Amgen Company Details
Table Amgen Revenue in Cancer Therapies Business (2014-2019) (Million US$)
Figure Amgen Revenue Growth Rate in Cancer Therapies Business (2014-2019)
Table Amgen Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Cancer Therapies Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Cancer Therapies Business (2014-2019)
Table AstraZeneca Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Cancer Therapies Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Cancer Therapies Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Bayer AG Company Details
Table Bayer AG Revenue in Cancer Therapies Business (2014-2019)(Million US$)
Figure Bayer AG Revenue Growth Rate in Cancer Therapies Business (2014-2019)
Table Bayer AG Recent Development
Table F. Hoffmann-La Roche Ltd Company Details
Table F. Hoffmann-La Roche Ltd Revenue in Cancer Therapies Business (2014-2019)(Million US$)
Figure F. Hoffmann-La Roche Ltd Revenue Growth Rate in Cancer Therapies Business (2014-2019)
Table F. Hoffmann-La Roche Ltd Recent Development
Table GlaxoSmithKline PLC Company Details
Table GlaxoSmithKline PLC Revenue in Cancer Therapies Business (2014-2019)(Million US$)
Figure GlaxoSmithKline PLC Revenue Growth Rate in Cancer Therapies Business (2014-2019)
Table GlaxoSmithKline PLC Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Cancer Therapies Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Cancer Therapies Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Merck & Co. Inc. Company Details
Table Merck & Co. Inc. Revenue in Cancer Therapies Business (2014-2019)(Million US$)
Figure Merck & Co. Inc. Revenue Growth Rate in Cancer Therapies Business (2014-2019)
Table Merck & Co. Inc. Recent Development
Table Novartis AG Company Details
Table Novartis AG Revenue in Cancer Therapies Business (2014-2019)(Million US$)
Figure Novartis AG Revenue Growth Rate in Cancer Therapies Business (2014-2019)
Table Novartis AG Recent Development
Table Pfizer Inc. Company Details
Table Pfizer Inc. Revenue in Cancer Therapies Business (2014-2019)(Million US$)
Figure Pfizer Inc. Revenue Growth Rate in Cancer Therapies Business (2014-2019)
Table Pfizer Inc. Recent Development
Table Global Cancer Therapies Market Size by Regions (Million US$) 2019-2025
Figure Global Cancer Therapies Market Size Share by Regions (2019-2025)
Figure Global Cancer Therapies Market Size Share by Regions in 2025
Figure United States Cancer Therapies Market Size Forecast (2019-2025)(Million USD)
Figure Europe Cancer Therapies Market Size Forecast (2019-2025)(Million USD)
Figure China Cancer Therapies Market Size Forecast (2019-2025)(Million USD)
Figure Japan Cancer Therapies Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Cancer Therapies Market Size Forecast (2019-2025)(Million USD)
Figure India Cancer Therapies Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Cancer Therapies Market Size Forecast (2019-2025)(Million USD)
Table Global Cancer Therapies Market Size by Product (2019-2025) (Million US$)
Figure Global Cancer Therapies Market Size by Product (2019-2025)
Figure Global Cancer Therapies Market Size by Product in 2025
Table Global Cancer Therapies Market Size by Application (2019-2025) (Million US$)
Figure Global Cancer Therapies Market Size by Application (2019-2025)
Figure Global Cancer Therapies Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
卵巣癌遺伝子治療の世界市場：市場規模・現状・予測 Ovarian cancer occurs and arises from several types of cells within the ovary, and it has the lowest survival rate of all gynecological cancers. Among many types, epithelial ovarian cancer (EOC) is the most common ovarian cancer, whereas ovarian low malignant potential tumor (OLMPT), germ cell tumor…- がん遺伝子治療の世界市場：市場規模・現状・予測 Cancer could be defined as uncontrolled cell growth in the body leading to organ malfunction. If untreated, it can lead to death. Uncontrolled growth of cell is managed by the body in several ways, one of them is by deploying white blood cells to detect and eradicate these cancerous cells. It has be…
- 子宮頸がん用治療及び診断の世界市場：市場規模・現状・予測 Therapies and Diagnostics for Cervical Cancer refers to a series of methods and medical devices that can be used for the diagnosis and treatment of cervical cancer.The factors that are driving the cervical cancer market are HPV infection, women having many sexual partners, women getting sexually act…
- 子宮頸がん用治療及び診断の世界市場：市場規模・現状・予測 Therapies and Diagnostics for Cervical Cancer refers to a series of methods and medical devices that can be used for the diagnosis and treatment of cervical cancer.The factors that are driving the cervical cancer market are HPV infection, women having many sexual partners, women getting sexually act…
- 犬幹細胞療法の世界市場：市場規模・現状・予測 The non-invasive stem cell obtaining procedure, augmented possibility of accomplishing high quality cells, and lower price of therapy coupled with high success rate of positive outcomes have collectively made allogeneic stem cell therapy a preference for veterinary physicians. Moreover, allogeneic s…